How A UK Tech Start-Up Is Disrupting Men’s Health
HBW Insight talks to Numan's chief medical strategy officer Professor Sam Shah about how the UK tech start-up is bringing innovation to the country's men's health category.
You may also be interested in...
US and EU OTC approval for Futura's drug-free erectile dysfunction treatment MED3000 edges closer, following the company's submission of its EU dossier and a second pre-submission meeting with the FDA.
Premature ejaculation treatment Fortacin is set to become only the fifth drug to achieve an Rx-to-OTC switch through EMA's centralized procedure, expanding the burgeoning OTC men's sexual health category.
Pfizer is investing roughly $10m in Viagra Connect in the UK to help raise awareness of erectile problems among the country's male population.